The United States Recombinant Therapeutic Antibodies And Proteins Market is further driven by a strong biotechnology ecosystem, extensive clinical research, increasing approvals of biologic therapies, advanced manufacturing capabilities, and strategic partnerships focused on next-generation therapeutic products. Growing investments in protein engineering, cell culture technologies,...